Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 28, 2014 - Issue 10
335
Views
20
CrossRef citations to date
0
Altmetric
Articles

Sensitisation of ovarian cancer cells to cisplatin by flavonoids from Scutellaria barbata

, , , , , & show all
Pages 683-689 | Received 21 Oct 2013, Accepted 28 Nov 2013, Published online: 20 Dec 2013

References

  • Arafael-SA, ZhuQ, BarakatBM, WaniG, ZhaoQ, El-MahdyMA, WaniAA. 2009. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res. 69:8910–8917.
  • GohD, LeeYH, OngES. 2005. Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem. 53:8197–8204.
  • Jiangsu New Medical College. 1977. Dictionary of Chinese Materia Medical. Shanghai: Science and Technology Press of Shanghai.
  • KhanN, HadiN, AfaqF, SyedDN, KweonMH, MukhtarH. 2007. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis. 28:163–173.
  • KosmiderB, OsieckaR. 2004. Flavonoid compounds: a review of anticancer properties and interactions with cis-diamminedichloroplatinum(II). Drug Develop Res. 63:200–211.
  • LiCJ, ChuCY, HuangLH, WangMH, SheuLF, YehJI, HsuHY. 2012. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett. 319:203–213.
  • LiuLZ, HuXW, XiaC, HeJ, ZhouQ, ShiX, FangJ, JiangBH. 2006. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Rad Biol Med. 41:1521–1533.
  • LuoH, DaddysmanMK, RankinGO, JiangBH, ChenYC. 2010. Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int. 10:16.
  • NamTW, YooCI, KimHT, KwonCH, ParkJY, KimYK. 2008. The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts. J Bone Min Metab. 26:551–560.
  • NijveldtRJ, NoodE, HoornDEC, BoelensPG, NorrenK, LeeuwenPAM. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 74:418–425.
  • PinatoDJ, GrahamJ, GabraH, SharmaR. 2013. Evolving concepts in the management of drug resistant ovarian cancer: dose dense chemotherapy and the reversal of clinical platinum resistance. Cancer Treatment Rev. 39:153–160.
  • SerpeloniJM, BarcelosGR, Friedmann AngeliJP, MercadanteAZ, Lourdes Pires BianchiM, AntunesLM. 2012. Dietary carotenoid lutein protects against DNA damage and alterations of the redox status induced by cisplatin in human derived HepG2 cells. Toxicol in Vitro. 26:288–294.
  • ShiR, HuangQ, ZhuX, OngYB, ZhaoB, LuJ, OngCN, ShenHM. 2007. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Therapeutics. 6:1338–1347.
  • WangW, SunY, LiX, LiH, ChenY, TianY, YiJ, WangJ. 2011. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression. Oncol Rep. 26:1143–1148.
  • WeiW, MokSC, OlivaE, KimSH, MohapatraG, BirrerMJ. 2013. FGF18 as a prognostic and therapeutic biomarker in ovarian cancer. J Clin Invest. 123:4435–4448.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.